Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel heterogeneous rhodium catalyst system for butadiene hydroformylation. High selectivity, easy separation, and significant cost efficiency for industrial chemical manufacturing processes.
Patent CN116789712A reveals solvent-free rhodium-catalyzed synthesis. Delivers high-purity ferrocene derivatives with significant cost and supply chain advantages.
Patent CN111270260B reveals a green Rh-catalyzed C-H activation route using electricity, offering cost-effective API intermediate manufacturing without external oxidants.
Patent CN105566202A reveals a novel Rh-Cu catalyzed one-pot synthesis for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102295582A reveals a novel rhodium-catalyzed three-component reaction for high-purity alpha-quaternary carbon diamino acids, offering significant cost reduction in API manufacturing.
Patent CN111138350B reveals a high-yield asymmetric synthesis route for dexchlorpheniramine, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN1972898A details a novel Rh-catalyzed asymmetric hydrogenation process for unprotected beta-amino acids, offering significant cost reduction and streamlined API manufacturing.
Novel Reppe synthesis route for strawberry acid using Rh-catalysis. High yield, green chemistry, cost-effective manufacturing for flavor industry.
Advanced rhodium-catalyzed route for MDJ production offering cost reduction and supply chain reliability for fragrance manufacturers globally.
Patent CN100422184C details a telescoped synthesis for Meropenem, improving yield and reducing solvent use for reliable pharmaceutical intermediate supply.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN111270260A introduces a green electrochemical Rh-catalyzed alkenylation method, offering cost reduction and scalable solutions for fine chemical manufacturing.
Patent CN103373948A details a high-yield 6-step asymmetric synthesis of (-)-Kainic Acid using Rh-catalysis, offering a reliable alternative to natural extraction for neuroscience research.
Patent CN112625020B details a novel Rh-catalyzed C-H activation route for isocoumarin derivatives, offering improved atom economy and supply chain reliability for pharmaceutical intermediates.
Efficient rhodium-catalyzed asymmetric cyclopropanation for antiviral drug intermediates. High enantioselectivity and scalable process for pharmaceutical manufacturing.
Novel Pauson-Khand route reduces costs and improves yield for high-purity methyl dihydrojasmonate manufacturing suitable for fragrance industry scale-up.
Advanced manufacturing of L-Phenylephrine HCl using optimized Rh-catalysis for high purity and cost-effective supply chain solutions.
Patent CN114988991B reveals novel rhodium-phosphine catalyst system enhancing isomeric aldehyde selectivity for cost-effective fine chemical intermediate manufacturing supply chains.